BiostatisticianDr. Yi – Senior ScienceDocs Biostatistician

Dr. Yi has a PhD in Medical Statistics and has worked as a biostatistician since 1985.  An expert in SAS statistical software, Dr. Yi has been a Senior Biostatistician at ScienceDocs since 2008 and has also served as the same role for the Canadian Blood Services, as well as the University of Ottawa, where he has served as an Adjunct Professor.  Prior to that, Dr. Yi has a distinguished career as an Assistant Professor in Medical Statistics, School of Public Health, Shanghai Medical University (China), a Statistical Consultant for Pasteur Merieux Connaught Company (France), a Biostatistician for Canadian Cardiovascular Collaboration at McMaster University (Canada), and a Biostatistician, Princess Margaret Hospital and an Associate Professor, Public Health Sciences at University of Toronto.  He specializes in medical study design, sample size and power calculation, and complex data analysis  in the fields of clinical trial,  epidemiology, lab experiment, genetics and public health in cancer and other chronic disease studies that require substantial inferential statistical methodology.  An abbreviated list of some of his co-authored 170 papers are listed below.

To work with ScienceDocs Biostatistician Dr. Yi, please visit our quote page and request him in the description area.



  1. Yi Q, Wang PP, He Y. Reliability analysis for continuous measurements: Equivalence test for agreement. Stat Med.  2008 Jul 10;27(15):2816-25.
  2. Yi Q. Panzarella T. Corey P. Incorporating the sampling variation of the disease prevalence when calculating the sample size in a study to determine the diagnostic accuracy of a test. . [Journal Article] Controlled Clinical Trials. 2004 August 2004, Pages 417-427
  3. Yi Q. Wang PP. Krahn M. Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection. Journal of Viral Hepatitis. 11(2):166-74, 2004 Mar.
  4. Yi Q. Panzarella T. Estimating sample size for tests on trends across repeated measurements with missing data based on the interaction term in a mixed model. [Journal Article] Controlled Clinical Trials. 23(5):481-96, 2002 Oct.
  5. Taha M, Kalab M, Yi QL, Maurer E, Jenkins C, Schubert P, Ramirez-Arcos S. Bacterial survival and distribution during buffy coat platelet production. Vox Sang. 2016 Jul 19.
  6. O’Brien SF, Yi QL. How do I interpret a confidence interval? Transfusion. 2016 Jul;56(7):1680-3. doi: 10.1111/trf.13635.
  7. Jordan A, Chen D, Yi QL, Kanias T, Gladwin MT, Acker JP. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang. 2016 Jul;111(1):8-15.
  8. O’Brien SF, Osmond L, Fan W, Yi QL, Goldman M. Impact of a 5-year deferral from blood donation for men who have sex with men. 2016 Jun;56(6 Pt 2):1598-602.
  9. Acker JP, Hansen AL, Yi QL, Sondi N, Cserti-Gazdewich C, Pendergrast J, Hannach B.
  10. Introduction of a closed-system cell processor for red blood cell washing: postimplementation monitoring of safety and efficacy. 2016 Jan;56(1):49-57.
  11. O’Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi QL, Fearon MA. Seroprevalence of Babesia microti infection in Canadian blood donors. Transfusion. 2016 Jan;56(1):237-43.
  12. O’Brien SF, Osmond  L and Yi QL. How do I interpret a p value?  Transfusion,  Volume 55, Issue 12, pages 2778–2782, December 2015
  13. Thein HH, Khoo E, Campitelli MA, Zaheen A, Yi Q, De P, Earle CC. Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study. CMAJ Open. 2015 Apr 2;3(2): E208-16
  14. O’Brien SF, Osmond L, Choquet K, Yi QL, Goldman M. Donor attention to reading materials. Vox Sang. 2015 Nov;109(4):336-42
  15. Palmer DS, Scalia V, O’Toole J, Welch C, Yi Q, Goldman M. Incidence of gammopathies in long-term plasmapheresis donors at Canadian Blood Services. 2015 ;55(6):1347-54.
  16. Alam A, Huang M, Yi QL, Lin Y, Hannach B. Perioperative transfusion-related acute lung injury: the Canadian Blood Services experience. Transfus Apher Sci. 2014 Jun;50(3):392-8.
  17. Hansen AL, Turner TR, Yi QL, Acker JP. Quality of red blood cells washed using an automated cell processor with and without irradiation. Transfusion. 2014 Jun;54(6):1585-94. doi: 10.1111/trf.12489. Epub 2013 Nov 14.
  18. O’Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA. Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer “no” to risk questions. 2014 Mar;54(3 Pt 2):863-9.
  19. McKelvey K, Attonito J, Madhivanan P, Yi Q, Mzayek F, Maziak W. Nicotine Tob Res. Determinants of Cigarette Smoking Initiation in Jordanian Schoolchildren: Longitudinal Analysis. 2014 Aug 20
  20. McKelvey K, Attonito J, Madhivanan P, Jaber R, Yi Q, Mzayek F, Maziak W. Determinants of waterpipe smoking initiation among school children in Irbid, Jordan: a 4-year longitudinal analysis. Drug Alcohol Depend. 2014 Sep 1;142:307-13
  21. Taha M, Kalab M, Yi QL, Landry C, Greco-Stewart V, Brassinga AK, Sifri CD, Ramirez-Arcos S. Biofilm-forming skin microflora bacteria are resistant to the bactericidal action of disinfectants used during blood donation. 2014 Nov;54(11):2974-82
  22. O’brien SF, Xi G, Fan W, Yi QL, Osmond L, Delage G, Goldman M. Are donors in Canada compliant with deferral for tattoos and piercing? Blood Transfus. 2014 Jan;12(1):141-2.
  23. Hansen AL, Turner TR, Yi QL, Acker JP. Quality of red blood cells washed using an automated cell processor with and without irradiation. Transfusion. 2013 Nov 14.
  24. Lieberman L, Maskens C, Cserti-Gazdewich C, Hansen M, Lin Y, Pendergrast J, Yi QL, Callum J. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev. 2013 Oct;27(4):206-12.
  25. Mastronardi C, Schubert P, Levin E, Bhakta V, Yi QL, Hansen A, Stewart T, Jenkins C, Lefresne W, Sheffield W, Acker JP. Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method. J Blood Transfus. 2013;2013:154838.
  26. O’Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med. 2013 Jul 17.
  27. Lieberman L, Petraszko T, Yi QL, Hannach B, Skeate R. Transfusion-related lung injury in children: a case series and review of the literature. Transfusion. 2014 Jan;54(1):57-64.
  28. O’Brien SF, Uzicanin S, Choquet K, Yi QL, Fan W, Goldman M. Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals. Blood Transfus. 2013 Oct;11(4):580-4.
  29. O’Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA. Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer “no” to risk questions. Transfusion. 2014 Mar;54(3 Pt 2):863-9.
  30. Hansen A, Yi QL, Acker JP. Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions. 2013 Mar 22. doi: 10.1111/trf.12170. [Epub ahead of print]
  31. Chen Y, Mo F, Yi Q, Morrison H, Mao Y.Association between mental health and fall injury in Canadian immigrants and non-immigrants. Accid Anal Prev. 2013 Oct;59:221-6.
  32. Cavalieri M, Schmidt R, Chen C, Mok V, de Freitas GR, Song S, Yi Q, Ropele S, Grazer A, Homayoon N, Enzinger C, Loh K, Wong KS, Wong A, Xiong Y, Chang HM, Wong MC, Fazekas F, Eikelboom JW, Hankey GJ; VITATOPS Trial Study Group. B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy. Stroke. 2012 Dec;43(12):3266-70.
  33. Gommans J1, Yi Q, Eikelboom JW, Hankey GJ, Chen C, Rodgers H; VITATOPS trial study group. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatr. 2013 Sep 3;13:88.
  34. Chen Y, Mo F, Yi QL, Jiang Y, Mao Y. Unintentional injury mortality and external causes in Canada from 2001 to 2007. Chronic Dis Inj Can. 2013 Mar;33(2):95-102.
  35. Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J. Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule. Vox Sang. 2013 Feb 9. doi: 10.1111/vox.12027. [Epub ahead of print]
  36. Goldman M, Osmond L, Yi QL, Cameron-Choi K, O’Brien SF. Frequency and risk factors for donor reactions in an anonymous blood donor survey. 2012 Dec 11. doi: 10.1111/trf.12011. [Epub ahead of print]
  37. O’Brien SF, Shao ZJ, Osmond L, Yi QL, Li CY, An QX. Donor motivation in Xi’an, China: comparison with Canadian donors. Vox Sang. 2012 Oct 16.
  38. O’Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Dines IR, Huang M, Ndao M, Fearon MA Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services. Transfusion. 2012 Nov 12
  39. Fan W, Yi QL, Xi G, Goldman M, Germain M, O’Brien SF.The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada. Transfus Med. 2012 Dec;22(6):395-403.
  40. Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J. Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth. 2012 Jul 31.
  41. Goldman M, Uzicanin S, Yi QL, Acker J, Ramirez-Arcos S. Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services. 2012 Jul;52(7 Pt 2):1607-13.
  42. Acker JP, M Croteau I, Yi QL. An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches. Clin Chim Acta. 2012 Nov 12;413(21-22):
  43. Semple E, Bowes-Schmidt A, Yi QL, Shimla S, Devine DV. Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood. 2012 Jun 28
  44. O’Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang. 2012 Jul;103(1):83-6
  45. Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; on behalf of the VITAmins TO Prevent Stroke (VITATOPS) Trial Study Group. Treatment With B Vitamins and Incidence of Cancer in Patients With Previous Stroke or Transient Ischemic Attack: Results of a Randomized Placebo-Controlled Trial. Stroke. 2012 Apr 3. [Epub ahead of print]
  46. Goldman M, Yi QL, Ye X, Tessier L, O’Brien SF. Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior. Page 1537-2995.
  47. Greco CA, Zhang JG, Kalab M, Yi QL, Ramirez-Arcos SM, Gyongyossy-Issa MI. Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates.  Transfusion. 2010 Nov;50(11):2344-52.  
  48. VITATOPS Trial Study Group B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010 Sep;9(9):855-65. Epub 2010 Aug 3.
  49. Palmer DS, O’Toole J, Montreuil T, Scalia V, Yi QL, Goldman M, Towns D. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. 2010 Jul;50(7):1524-31. Epub 2010 Feb 11.
  50. Cassinotti E, Melson J, Liggett T, Melnikov A, Yi Q, Replogle C, Mobarhan S, Boni L, Segato S, Levenson V. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26484. [Epub ahead of print]
  51. Raju NC, Yi Q, Nidorf M, Fagel ND, Hiralal R, Eikelboom JW. Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial. J Thromb Thrombolysis. 2011 Sep 15. [Epubahead of print]
  52. Liggett TE, Melnikov A, Yi Q, Replogle C, Hu W, Rotmensch J, Kamat A, Sood AK, Levenson V. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol. 2011 Jan;120(1):113-20
  53. Liggett T, Melnikov A, Yi QL, Replogle C, Brand R, Kaul K, Talamonti M, Abrams RA, Levenson V. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. 2010 Apr 1;116(7):1674-80
  54. Chen Y, Wu J, Yi QL. Reduced risk of hospitalization associated with influenza vaccination in Canada. 2010 Mar 8;28(11):2290-5
  55. Liggett T, Melnikov A, Tilwalli S, Yi Q, Chen H, Replogle C, Feng X, Reder A, Stefoski D, Balabanov R, Levenson V. Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci. 2010 Mar 15;290(1-2):16-21. Epub 2010 Jan 12
  56. Mar Fan HG, Houédé-Tchen N, Chemerynsky I, Yi QL, Xu W, Harvey B, Tannock IF. Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. 2010 May;21(5):983-7.
  57. O’Brien SF, Xi G, Yi QL, Goldman M. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med. 2010 Feb;20(1):15-21.
  58. O’Brien SF, Fan W, Xi G, Yi QL, Goldman M. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience. Vox Sang. 2010 Feb;98(2):138-44.
  59. Maurer-Spurej E, Labrie A, Pittendreigh C, Chipperfield K, Smith C, Heddle N, Liu Y, Yi QL, Barnett M. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. 2009 Nov;49(11):2276-84.
  60. O’Brien SF, Yi QL, Fan W, Fearon MA, Scalia V, Goldman M. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. 2009 Feb;49(2):271-7.
  61. Goldman M, Xi G, Yi QL, Fan W, O’Brien SF. Reassessment of deferrals for tattooing and piercing. Transfusion. 2009 Feb;49(2):271-7.
  62. Panton RL, Downie R, Truong T, Mackeen L, Kabene S, Yi QL, Chan HS, Gallie BL. A visual approach to providing prognostic information to parents of children with retinoblastoma. 2009 Mar;18(3):300-4.
  63. Thein HH, Yi Q, Heathcote EJ, Krahn MD. Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort. J Viral Hepat. 2009 Apr 27.
  64. Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E. The Prognostic Significance of Bundle Branch Block in High-Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial. J Cardiovasc Electrophysiol. 2009 Feb 26..
  65. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008 Oct 7;149(7):481-90, W94. Review.
  66. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008 Oct 1;22(15):1979-91. Review.
  67. VITATOPS Trial Study Group. VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444). Int J Stroke. 2007 May;2(2):144-50.
  68. O’Brien SF, Xi G, Fan W, Yi QL, Fearon MA, Scalia V, Goldman M. Epidemiology of hepatitis B in Canadian blood donors . Transfusion. 2008 Nov;48(11):2323-30. Epub 2008 Jul 11.
  69. Fan HG, Park A, Xu W, Yi QL, Braganza S, Chang J, Couture F, Tannock IF.  The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.  Psychooncology. 2009 Feb;18(2):156-61.
  70. Chen Y, Yi Q, Mao Y. Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002. Int J Health Geogr. 2008 Jun 2;7:28.
  71. Chen Y, Wu J, Yi Q, Huang G, Wong T. Depression associated with sexually transmitted infection (STI) in Canada . Sex Transm Infect. 2008 Dec;84(7):535-40.
  72. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression. Hepatology. 2008 Aug;48(2):418-31. Review
  73. O’Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M, Delage G. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies.Transfusion. 2008 May;48(5):902-9.
  74. O’Brien SF, Ram SS, Yi QL, Goldman M. Donor’s understanding of the definition of sex as applied to predonation screening questions.Vox Sang. 2008 May;94(4):329-33.
  75. O’Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion. 2008 Apr;48(4):755-61
  76. Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S; Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J. 2007 Oct;154(4):743-50.
  77. O’brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion. 2007 Oct;47(10):1809-15.
  78. O’Brien SF, Yi QL, Fan W, Scalia V,Kleinman SH,Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.Transfusion. 2007 Feb;47(2):316-25.
  79. Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C; on behalf of the HOPE-2 investigators.Venous thromboembolism in association with features of the metabolic syndrome. QJM. 2007 Nov;100(11):679-84.
  80. Chen Y, Yi QL, Wu J, Li F. Chronic disease status, self-perceived health and hospital admissions are important predictors for having a flu shot in Canada. Vaccine. 2007 Oct 16;25(42):7436-40.
  81. Goldman M, Ram SS, Yi QL, Mazerall J, O’brien SF.The donor health assessment questionnaire: potential for format change and computer-assisted self-interviews to improve donor attention. Transfusion. 2007 Sep;47(9):1595-600.
  82. Sadikov E, Bezjak A, Yi QL, Wells W, Dawson L, Millar BA, Laperriere N. Value of whole brain re-irradiation for brain metastases–single centre experience. Clin Oncol (R Coll Radiol). 2007 Sep;19(7):532-8.
  83. Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007 Jul-Aug;25(4):303-9.
  84. Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007 Jul;134(1):188-93.
  85. Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E; Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
    Ann Intern Med. 2007 Jun 5;146(11):761-7.
  86. O’Brien SF, Yi QL, Fearon MA, Goldman M. A predonation screening question for occupational exposure to simian foamy virus: a preliminary donor survey in Canada. Transfusion. 2007 May;47(5):949-50.
  87. Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis. 2007 Oct;24(2):93-7.
  88. Sawka AM, Ray JG, Yi Q, Josse RG, Lonn E. Randomized clinical trial of homocysteine level lowering therapy and fractures.Arch Intern Med. 2007 Oct 22;167(19):2136-9. No abstract available
  89. Lin RY,Pitt TJ, Lou WY, Yi Q Asthma hospitalization patterns in young children relating to admission age, infection presence, sex, and race. Ann Allergy Asthma Immunol. 2007 Feb;98(2):139-45.
  90. Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology. 2006 Oct;15(10):921-30.
  91. Goldman M, Ram SS, Yi QL ,O’Brien SF. The Canadian donor health assessment questionnaire: can it be improved?Transfusion. 2006 Dec;46(12):2169-75.
  92. Zahariadis G, Plitt SS, O’brien S, Yi QL, Fan W, Preiksaitis JK. Prevalence and Estimated Incidence of Blood-Borne Viral Pathogen Infection in Organ and Tissue Donors from Northern Alberta. Am J Transplant. 2006 Nov 15;
  93. Vardy J, Wong K, Yi QL, Park A,Maruff P, Wagner L, Tannock IF. Assessing cognitive function in cancer patients. Support Care Cancer. 2006 Nov;14(11):1111-8. Epub 2006 Mar 15.
  94. Joly F, Alibhai SM, Galica J, Park A, Yi QL, Wagner L,Tannock IF. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol. 2006 Dec;176(6 Pt 1):2443-7.
  95. Staton JM, Sayer MS, Hankey GJ, Attia J, Thakkinstian A, Yi Q, Cole VJ, Baker R, Eikelboom JW. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1067-9.
  96. Chang H, Yeung J, Brandwein J, Yi QL. CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk Res. 2006 Jul 10;
  97. Gupta V, Brooker C, Tooze JA, Yi QL,Sage D, Turner D, Kangasabapathy P, Marsh JC. Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults.
    Br J Haematol. 2006 Jul;134(1):95-9.
  98. Chang H, Yi QL. Acute myeloid leukemia with pseudo-Chediak-Higashi anomaly exhibits a specific immunophenotype with CD2 expression. Am J Clin Pathol. 2006 May;125(5):791-4.
  99. Chen CI, Nanji S,Prabhu A, Beheshti R, Yi QL, Sutton D, Stewart AK. Sequential, cycling maintenance therapy for post transplant multiple myeloma. Bone Marrow Transplant. 2006 Jan;37(1):89-94.
  100. Witkos M, Yi QL, Heathcote J, Kapral MK, Krahn MD. Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients. Can J Gastroenterol. 2006 Feb;20(2):107-11
  101. Chang H, Samiee S, Yi QL. Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant. Leuk Lymphoma. 2006 Jan;47(1):43-7.
  102. Fan HG, Houede-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005 Nov 1;23(31):8025-32.
  103. Wang Y, Cummings B, Catton P, Dawson L, Kim J, Ringash J, Wong R, Yi QL, Brierley J. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients.
    Radiother Oncol. 2005 Nov;77(2):126-32. Epub 2005 Oct 10.
  104. Gupta V, Daly A, Lipton JH, Hasegawa W, Chun K, Kamel-Reid S, Tsang R, Yi QL, Minden M, Messner H, Kiss T. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. Biol Blood Marrow Transplant. 2005 Oct;11(10):764-72.
  105. Chang H, Qi XY, Samiee S, Yi QL, Chen C, Trudel S, Mikhael J, Reece D, Stewart AK. Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation. Bone Marrow Transplant. 2005 Nov;36(9):793-6.
  106. Carolan H, Sun AY, Bezjak A, Yi QL, Payne D, Kane G, Waldron J, Leighl N, Feld R, Burkes R, Keshavjee S, Shepherd F. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer. 2005 Jul;49(1):109-15. Epub 2005 Feb 2.
  107. Brandwein JM, Gupta V, Wells RA, Schuh AC, Schimmer AD, Lipton JH, Messner HA, Yi QL, Chun K, Kamel-Reid S, Minden MD. Treatment of elderly patients with acute lymphoblastic leukemia–evidence for a benefit of imatinib in BCR-ABL positive patients. Leuk Res. 2005 Dec;29(12):1381-6. Epub 2005 May 31.
  108. Chang H, Samiee S, Yi QL.Prognostic relevance of CD56 expression in multiple myeloma: A study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant. Leuk Lymphoma. 2006 Jan;47(1):43-7.
  109. Chang H, Bartlett ES, Patterson B, Chen CI, Yi QL. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system. Br J Haematol. 2005 May;129(4):539-41.
  110. Gupta V, Chun K, Yi QL, Minden M, Schuh A, Wells R, Brandwein J. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Cancer. 2005 May 15;103(10):2082-90.
  111. Gupta V, Gordon-Smith EC, Cook G, Parker A, Duguid JK, Wilson KM, Yi QL, Marsh JC. A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders. Br J Haematol. 2005 Apr;129(1):110-7.
  112. Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, Bosch J; HOPE Investigators. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Clin Nephrol. 2005 Mar;63(3):181-7.
  113. Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.J Thromb Haemost. 2005 Dec;3(12):2649-55.
  114. Darling GE, Abdurahman A, Yi QL, Johnston M, Waddell TK, Pierre A, Keshavjee S, Ginsberg R. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg. 2005 Feb;79(2):433-7.
  115. Krahn MD, John-Baptiste A, Yi Q, Doria A, Remis RS, Ritvo P, Friedman S. Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada. Vaccine. 2005 Feb 18;23(13):1549-58.
  116. Chang H, Stewart AK, Qi XY, Li ZH, Yi QL, Trudel S. Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma.Blood. 2005 Mar 10; [Epub ahead of print]
  117. Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S; on behalf of the HOPE Trial Investigators. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):75-81.
  118. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J. 2005 Jan;149(1):54-60.
  119. Hankey GJ, Eikelboom JW, Loh K, Tang M, Pizzi J, Thom J, Yi Q. Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population. Cerebrovasc Dis. 2005;19(2):110-6. Epub 2004 Dec 17.
  120. Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, Ortin M, Freires M, Hale G, Waldmann H, Gordon-Smith EC, Marsh JC. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biol Blood Marrow Transplant. 2004 Dec;10(12):867-76.
  121. Dusitanond P, Eikelboom JW, Hankey GJ, Thom J, Gilmore G, Loh K, Yi Q, Klijn CJ, Langton P, van Bockxmeer FM, Baker R, Jamrozik K. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Stroke. 2005 Jan;36(1):144-6. Epub 2004 Nov 29.
  122. Thom J, Gilmore G, Yi Q, Hankey GJ, Eikelboom JW. Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma. J Thromb Haemost. 2004 Nov;2(11):2067-9. No abstract available.
  123. Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Leuk Res. 2005 Jan;29(1):113-4.
  124. Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl. 2004 Nov;(92):S59-62. Review.
  125. Chang H, Qi C, Yi QL, Reece D, Stewart AK. p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation. Blood. 2005 Jan 1;105(1):358-60. Epub 2004 Aug 31.
  126. Hankey GJ, Eikelboom JW, Loh K, Yi Q, Pizzi J, Tang M, Hickling S, Le M, Klijn CJ, Dusitanond P, van Bockxmeer F, Gelavis A, Baker R, Jamrozik K. Is there really a power shortage in clinical trials testing the “homocysteine hypothesis?”. Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e147. No abstract available.
  127. Chang H, Brandwein J, Yi QL, Chun K, Patterson B, Brien B. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004 Oct;28(10):1007-11.
  128. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population.
    Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1509-15. Epub 2004 Jun 17.
  129. Lonn E. Shaikholeslami R. Yi Q. Bosch J. Sullivan B. Tanser P. Magi A. Yusuf S. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.[see comment]. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Journal of the American College of Cardiology. 43(12):2200-6, 2004 Jun 16.
  130. Theal M. Sleik K. Anand S. Yi Q. Yusuf S. Lonn E. Prevalence of mitral valve prolapse in ethnic groups. [Journal Article] Canadian Journal of Cardiology. 20(5):511-5, 2004 Apr.
  131. Gupta V. Yi QL. Brandwein J. Minden MD. Schuh AC. Wells RA. Chun K. Kamel-Reid S. Tsang R. Daly A. Kiss T. Lipton JH. Messner HA. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison. [Journal Article] Bone Marrow Transplantation. 33(4):397-404, 2004 Feb.
  132. Theal M. Sleik K. Anand S. Yi Q. Yusuf S. Lonn E. Prevalence of mitral valve prolapse in ethnic groups. [Journal Article] Canadian Journal of Cardiology. 20(5):511-5, 2004 Apr.
  133. Chang H. Sloan S. Li D. Zhuang L. Yi QL. Chen CI. Reece D. Chun K. Keith Stewart A. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. [Journal Article] British Journal of Haematology. 125(1):64-8, 2004 Apr.
  134. Mann JF. Gerstein HC. Yi QL. Franke J. Lonn EM. Hoogwerf BJ. Rashkow A. Yusuf S. HOPE Investigators. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] American Journal of Kidney Diseases. 42(5):936-42, 2003 Nov.
  135. Chang H. Salma F. Yi QL. Patterson B. Brien B. Minden MD. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. [Journal Article] Leukemia Research. 28(1):43-8, 2004 Jan.
  136. Cole VJ. Staton JM. Eikelboom JW. Hankey GJ. Yi Q. Shen Y. Berndt MC. Baker RI. Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic stroke. [Journal Article] Journal of Thrombosis & Haemostasis. 1(5):963-70, 2003 May.
  137. Dagenais GR. Auger P. Bogaty P. Gerstein H. Lonn E. Yi Q. Yusuf S. HOPE Study Investigators. Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Canadian Journal of Cardiology. 19(12):1387-91, 2003 Nov.
  138. Tchen N. Juffs HG. Downie FP. Yi QL. Hu H. Chemerynsky I. Clemons M. Crump M. Goss PE. Warr D. Tweedale ME. Tannock IF. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. [Journal Article] Journal of Clinical Oncology. 21(22):4175-83, 2003 Nov 15.
  139. McQuillan AM. Eikelboom JW. Hankey GJ. Baker R. Thom J. Staton J. Yi Q. Cole V. Protein Z in ischemic stroke and its etiologic subtypes. [Journal Article] Stroke. 34(10):2415-9, 2003 Oct.
  140. Kelemen LE. Anand SS. Vuksan V. Yi Q. Teo KK. Devanesen S. Yusuf S. SHARE Investigators. Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese, and Europeans in North America. [Evaluation Studies. Journal Article] Journal of the American Dietetic Association. 103(9):1178-84, 2003 Sep.
  141. Cherian P. Hankey GJ. Eikelboom JW. Thom J. Baker RI. McQuillan A. Staton J. Yi Q. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. [Journal Article] Stroke. 34(9):2132-7, 2003 Sep.
  142. Tchen N. Bedard P. Yi QL. Klein M. Cella D. Eremenco S. Tannock IF. Quality of life and understanding of disease status among cancer patients of different ethnic origin. [Journal Article] British Journal of Cancer. 89(4):641-7, 2003 Aug 18.
  143. Chen X. Oza AM. Kusenda Z. Yi QL. Kochman D. Moore MJ. Davis AJ. Siu LL. Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours. [Clinical Trial. Clinical Trial, Phase I. Journal Article] British Journal of Cancer. 89(4):617-24, 2003 Aug 18.
  144. Anand SS. Yi Q. Gerstein H. Lonn E. Jacobs R. Vuksan V. Teo K. Davis B. Montague P. Yusuf S. Study of Health Assessment and Risk in Ethnic Groups. Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. [Journal Article] Circulation. 108(4):420-5, 2003 Jul 29.
  145. Gupta V. Minden MD. Yi QL. Brandwein J. Chun K. Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia. [Review] [58 refs] [Case Reports. Journal Article. Review. Review of Reported Cases] Leukemia Research. 27(11):983-91, 2003 Nov.
  146. Wang P. Yi Q. Scully L. Heathcote J. Krahn M. Indications for interferon/ribavirin therapy in hepatitis C patients: findings from a survey of Canadian hepatologists. [Journal Article] Canadian Journal of Gastroenterology. 17(3):183-6, 2003 Mar.
  147. Hasegawa W. Lipton JH. Messner HA. Jamal H. Yi QL. Daly AS. Kotchetkova N. Kiss TL. Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. [Review] [21 refs] [Journal Article. Review. Review, Multicase] Hematology. 8(1):27-33, 2003 Feb.
  148. Mann JF. Gerstein HC. Yi QL. Lonn EM. Hoogwerf BJ. Rashkow A. Yusuf S. Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. [Clinical Trial. Journal Article. Randomized Controlled Trial] Journal of the American Society of Nephrology. 14(3):641-7, 2003 Mar.
  149. Anand SS. Razak F. Vuksan V. Gerstein HC. Malmberg K. Yi Q. Teo KK. Yusuf S. Diagnostic strategies to detect glucose intolerance in a multiethnic population. [Evaluation Studies. Journal Article] Diabetes Care. 26(2):290-6, 2003 Feb.
  150. Eikelboom JW, Hankey GJ, Baker RI, McQuillan A, Thom J, Staton J, Cole V, Yi Q. C-reactive protein in ischemic stroke and its etiologic subtypes.J Stroke Cerebrovasc Dis. 2003 Mar-Apr;12(2):74-81.
  151. Smieja M. Gnarpe J. Lonn E. Gnarpe H. Olsson G. Yi Q. Dzavik V. McQueen M. Yusuf S. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.[see comment]. [Journal Article] Circulation. 107(2):251-7, 2003 Jan 21.
  152. Rayan G. Dawson LA. Bezjak A. Lau A. Fyles AW. Yi QL. Merante P. Vallis KA. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.[see comment]. [Clinical Trial. Journal Article. Randomized Controlled Trial] International Journal of Radiation Oncology, Biology, Physics. 55(1):154-61, 2003 Jan 1.
  153. Gerstein HC. Anand S. Yi QL. Vuksan V. Lonn E. Teo K. Malmberg K. McQueen M. Yusuf S. SHARE Investigators. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. [Journal Article] Diabetes Care. 26(1):144-9, 2003 Jan.
  154. Veres A. Fust G. Smieja M. McQueen M. Horvath A. Yi Q. Biro A. Pogue J. Romics L. Karadi I. Singh M. Gnarpe J. Prohaszka Z. Yusuf S. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.[see comment]. [Journal Article] Circulation. 106(22):2775-80, 2002 Nov 26.
  155. Lonn E. Yusuf S. Hoogwerf B. Pogue J. Yi Q. Zinman B. Bosch J. Dagenais G. Mann JF. Gerstein HC. HOPE Study. MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Diabetes Care. 25(11):1919-27, 2002 Nov.
  156. Lonn E. Roccaforte R. Yi Q. Dagenais G. Sleight P. Bosch J. Suhan P. Micks M. Probstfield J. Bernstein V. Yusuf S. HOPE Investigators. Heart Outcomes Prevention Evaluation. Effect of long-term therapy with ramipril in high-risk women. [Clinical Trial. Evaluation Studies. Journal Article. Randomized Controlled Trial] Journal of the American College of Cardiology. 40(4):693-702, 2002 Aug 21.
  157. Gupta M. Doobay AV. Singh N. Anand SS. Raja F. Mawji F. Kho J. Karavetian A. Yi Q. Yusuf S. Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects.[see comment]. [Journal Article] CMAJ Canadian Medical Association Journal. 166(6):717-22, 2002 Mar 19.
  158. Eikelboom JW. Hirsh J. Weitz JI. Johnston M. Yi Q. Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.[see comment]. [Journal Article] Circulation. 105(14):1650-5, 2002 Apr 9.
  159. Anand SS. Yusuf S. Jacobs R. Davis AD. Yi Q. Gerstein H. Montague PA. Lonn E. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).[see comment]. [Journal Article] Lancet. 358(9288):1147-53, 2001 Oct 6.
  160. Mathew J. Sleight P. Lonn E. Johnstone D. Pogue J. Yi Q. Bosch J. Sussex B. Probstfield J. Yusuf S. Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.[see comment]. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Circulation. 104(14):1615-21, 2001 Oct 2.
  161. Dagenais GR. Yusuf S. Bourassa MG. Yi Q. Bosch J. Lonn EM. Kouz S. Grover J. HOPE Investigators. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Circulation. 104(5):522-6, 2001 Jul 31.
  162. Gerstein HC. Mann JF. Yi Q. Zinman B. Dinneen SF. Hoogwerf B. Halle JP. Young J. Rashkow A. Joyce C. Nawaz S. Yusuf S. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.[see comment]. [Journal Article. Multicenter Study] JAMA. 286(4):421-6, 2001 Jul 25.
  163. Ho SC. Chan SG. Yi Q. Wong E. Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. [Clinical Trial. Journal Article] Journal of Bone & Mineral Research. 16(7):1363-9, 2001 Jul.
  164. Lonn E. Yusuf S. Dzavik V. Doris C. Yi Q. Smith S. Moore-Cox A. Bosch J. Riley W. Teo K. SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). [Clinical Trial. Journal Article. Randomized Controlled Trial] Circulation. 103(7):919-25, 2001 Feb 20.
  165. Whaley DA. Attfield MD. Bedillion EJ. Walter KM. Yi Q. Regression method to estimate provisional TLV/WEEL-equivalents for non-carcinogens. [Journal Article] Annals of Occupational Hygiene. 44(5):361-74, 2000 Aug.
  166. Ho SC. Chan SG. Yip YB. Cheng A. Yi Q. Chan C. Menopausal symptoms and symptom clustering in Chinese women. [Journal Article] Maturitas. 33(3):219-27, 1999 Dec 15.
  167. Schellenberg D. Yi Q. Glickman NW. Glickman LT. Influence of thoracic conformation and genetics on the risk of gastric dilatation-volvulus in Irish setters. [Journal Article] Journal of the American Animal Hospital Association. 34(1):64-73, 1998 Jan-Feb.
  168. Miller TD. Piegas LS. Gibbons RJ. Yi C. Yusuf S. Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction. [Journal Article] American Journal of Cardiology. 90(12):1370-4, 2002 Dec 15.
  169. Mehta SR. Eikelboom JW. Rupprecht HJ. Lewis BS. Natarajan MK. Yi C. Pogue J. Yusuf S. Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.[see comment]. [Clinical Trial. Journal Article. Randomized Controlled Trial] European Heart Journal. 23(2):117-23, 2002 Jan.
  170. Eikelboom JW. Anand SS. Mehta SR. Weitz JI. Yi C. Yusuf S. Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study. [Clinical Trial. Journal Article. Randomized Controlled Trial] Circulation. 103(5):643-50, 2001 Feb 6.
  171. Mehta SR. Eikelboom JW. Natarajan MK. Diaz R. Yi C. Gibbons RJ. Yusuf S. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. [Clinical Trial. Journal Article. Meta-Analysis. Multicenter Study. Randomized Controlled Trial] Journal of the American College of Cardiology. 37(1):37-43, 2001 Jan.
  172. Anand SS. Yusuf S. Vuksan V. Devanesen S. Teo KK. Montague PA. Kelemen L. Yi C. Lonn E. Gerstein H. Hegele RA. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). [Journal Article] Indian Heart Journal. 52(7 Suppl):S35-43, 2000 Nov-Dec.
  173. Anand SS. Yusuf S. Vuksan V. Devanesen S. Teo KK. Montague PA. Kelemen L. Yi C. Lonn E. Gerstein H. Hegele RA. McQueen M. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)[see comment]. [Journal Article] Lancet. 356(9226):279-84, 2000 Jul 22.


©2024 ScienceDocs Inc.


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials

Forgot your details?